Cytokine elevations in acute coronary syndrome and ovarian cancer: A mechanism for the up-regulation of the acute phase proteins in these different disease etiologies

被引：19

作者：

Kavsak, Peter A. ^{[1
]}

Lee, Agnes ^{[2
]}

Hirte, Hal ^{[3
]}

Young, Ed ^{[1
]}

Gauldie, Jack ^{[1
,4
]}

机构：

[1] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada

[2] McMaster Univ, Dept Med, Hamilton, ON, Canada

[3] McMaster Univ, Dept Oncol, Hamilton, ON, Canada

[4] McMaster Univ, Ctr Gene Therapeut, Hamilton, ON, Canada

来源：

CLINICAL BIOCHEMISTRY | 2008年 / 41卷 / 7-8期

关键词：

cytokines; myocardial infarction; ovarian cancer; profile;

D O I：

10.1016/j.clinbiochem.2008.01.019

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Objectives: To identify if a common set of cytokines is elevated in both ovarian cancer and acute coronary syndrome (ACS). Design and methods: A cytokine array (Randox Ltd) was measured in healthy women (n=33), women with ACS (n=21) and ovarian cancer (17-45). Results: Women with ACS or ovarian cancer had higher concentrations of IL-6, IL-8, VEGF, MCP-1, and EGF as compared to healthy volunteers. Discussion: Common cytokine elevations are present in both ACS and ovarian cancer. (C) 2008 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

引用

页码：607 / 610

页数：4

共 22 条

[1] Soluble epidermal growth factor receptor (SEG-FR) and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer [J].

Baron, AT ;

Boardman, CH ;

Lafky, JM ;

Rademaker, A ;

Liu, DC ;

Fishman, DA ;

Podratz, KC ;

Maihle, NJ .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (02) :306-318

[2] THE ACUTE-PHASE RESPONSE [J].

BAUMANN, H ;

GAULDIE, J .

IMMUNOLOGY TODAY, 1994, 15 (02) :74-80

[3] Biological determinants of and reference values for plasma interleukin-8, monocyte chemoattractant protein-1, epidermal growth factor, and vascular endothelial growth factor: Results from the STANISLAS cohort [J].

Berrahmoune, H ;

Lamont, JV ;

Herbeth, B ;

FitzGerald, P ;

Visvikis-Siest, S .

CLINICAL CHEMISTRY, 2006, 52 (03) :504-510

[4] Sites of interleukin-16 release in patients with acute coronary syndromes and in patients with congestive heart failure [J].

Deliargyris, EN ;

Raymond, RJ ;

Theoharides, TC ;

Boucher, WS ;

Tate, DA ;

Dehmer, GJ .

AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (09) :913-918

[5] Development of a high-throughput automated analyzer using biochip array technology [J].

FitzGerald, SP ;

Lamont, JV ;

McConnell, RI ;

Benchikh, EO .

CLINICAL CHEMISTRY, 2005, 51 (07) :1165-1176

[6] Interleukin-6 and chronic inflammation [J].

Gabay, Cem .

ARTHRITIS RESEARCH & THERAPY, 2006, 8 (Suppl 2)

[7] Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer [J].

Gorelik, E ;

Landsittel, DP ;

Marrangoni, AM ;

Modugno, F ;

Velikokhatnaya, L ;

Winans, MT ;

Bigbee, WL ;

Herberman, RB ;

Lokshin, AE .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (04) :981-987

[8] A phase III randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/platinurn containing chemotherapy: A National Cancer Institute of Canada Clinical Trials Group Study [J].

Hirte, H. ;

Vergote, I. B. ;

Jeffrey, J. R. ;

Grimshaw, R. N. ;

Coppieters, S. ;

Schwartz, B. ;

Tu, D. ;

Sadura, A. ;

Brundage, M. ;

Seymour, L. .

GYNECOLOGIC ONCOLOGY, 2006, 102 (02) :300-308

[9]

Jelkmann W, 2001, CLIN CHEM, V47, P617

[10] Upstream markers provide for early identification of patients at high risk for myocardial necrosis and adverse outcomes [J].

Kavsak, Peter A. ;

Ko, Dennis T. ;

Newman, Alice M. ;

Palomaki, Glenn E. ;

Lustig, Viliam ;

MacRae, Andrew R. ;

Jaffe, Allan S. .

CLINICA CHIMICA ACTA, 2008, 387 (1-2) :133-138

← 1 2 3 →